Keywords
Analysis
France
Racine
Analysis
France
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Analysis (France)

Index « Keywords » - entrée « Abatacept (therapeutic use) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Abatacept (pharmacology) < Abatacept (therapeutic use) < Abdominal Pain (etiology)  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 10.
Ident.Authors (with country if any)Title
000054 (2019) Maxime Samson [France] ; Hélène Greigert [France] ; Thibault Ghesquière [France] ; Bernard Bonnotte [France][Treatment of giant cell arteritis].
000067 (2019) Natalia Cabrera [France] ; Jean-Christophe Lega [France] ; Behrouz Kassai [France] ; Carine Wouters [Belgique] ; Anuela Kondi [France] ; Elvira Cannizzaro [Suisse] ; Andreas Woerner [Suisse] ; Aurelie Chausset [France] ; Samuel Roethlisberger [Suisse] ; Cyril Jeanneret [Suisse] ; Florence Aeschlimann [Suisse] ; Salma Malik [France] ; Agnès Duquesne [France] ; Daniela Kaiser [Suisse] ; Laetitia Higel [France] ; Anne Maes [Belgique] ; Gerald Berthet [Suisse] ; Veronique Hentgen [France] ; Isabelle Kone-Paut [France] ; Alexandre Belot [France] ; Michael Hofer [Suisse]Safety of biological agents in paediatric rheumatic diseases: A real-life multicenter retrospective study using the JIRcohorte database.
000113 (2019) Alexandre Virone [France] ; Jean-Philippe Bastard [France] ; Soraya Fellahi [France] ; Jacqueline Capeau [France] ; Stéphanie Rouanet [France] ; Jean Sibilia [France] ; Philippe Ravaud [France] ; Francis Berenbaum [France] ; Jacques-Eric Gottenberg [France] ; Jérémie Sellam [France]Comparative effect of tumour necrosis factor inhibitors versus other biological agents on cardiovascular risk-associated biomarkers in patients with rheumatoid arthritis
000159 (2018) Elodie Rivière [France] ; Jérémie Sellam [France] ; Juliette Pascaud [France] ; Philippe Ravaud [France] ; Jacques-Eric Gottenberg [France] ; Xavier Mariette [France]Serum IL-33 level is associated with auto-antibodies but not with clinical response to biologic agents in rheumatoid arthritis
000225 (2017) M. Samson [France] ; B. Bonnotte [France][From pathogenesis of giant cell arteritis to new therapeutic targets].
000226 (2017) Cosimo Bruni [Italie] ; Emanuela Praino [Italie] ; Yannick Allanore [France] ; Oliver Distler [Suisse] ; Armando Gabrielli [Italie] ; Florenzo Iannone [Italie] ; Marco Matucci-Cerinic [Italie]Use of biologics and other novel therapies for the treatment of systemic sclerosis.
000262 (2017) Nathalie Balandraud [France] ; Gaetan Texier [France] ; Emmanuel Massy [France] ; Olivier Muis-Pistor [France] ; Marielle Martin [France] ; Isabelle Auger [France] ; Marie-Caroline Guzian [France] ; Sandrine Guis [France] ; Thao Pham [France] ; Jean Roudier [France]Long term treatment with abatacept or tocilizumab does not increase Epstein-Barr virus load in patients with rheumatoid arthritis - A three years retrospective study
000302 (2016) Gaetane Nocturne [France] ; Divi Cornec [France] ; Raphaèle Seror [France] ; Xavier Mariette [France]Use of Biologics in Sjögren's Syndrome.
000315 (2016) Louise K. Mercer [Royaume-Uni] ; Johan Askling [Suède] ; Pauline Raaschou [Suède] ; William G. Dixon [Royaume-Uni] ; Lene Dreyer [Danemark] ; Merete Lund Hetland [Danemark] ; Anja Strangfeld [Allemagne] ; Angela Zink [Allemagne] ; Xavier Mariette [France] ; Axel Finckh [Suisse] ; Helena Canhao [Portugal] ; Florenzo Iannone [Italie] ; Jakub Zavada [République tchèque] ; Jacques Morel [France] ; Jacques-Eric Gottenberg [France] ; Kimme L. Hyrich [Royaume-Uni] ; Joachim Listing [Allemagne]Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: results from a collaborative project of 11 European biologic registers
000363 (2016) Tristan Pascart [France, Niger] ; Peggy Philippe [France] ; Elodie Drumez [France] ; Xavier Deprez [France] ; Bernard Cortet [France] ; Alain Duhamel [France] ; Eric Houvenagel [France] ; René-Marc Flipo [France]Comparative efficacy of tocilizumab, abatacept and rituximab after non‐TNF inhibitor failure: results from a multicentre study

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/France/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/KwdEn.i -k "Abatacept (therapeutic use)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/KwdEn.i  \
                -Sk "Abatacept (therapeutic use)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    France
   |étape=   Analysis
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Abatacept (therapeutic use)
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021